Single fraction stereotactic radiosurgery (SFSR) for lung tumors - A phase I dose escalation trial.

被引:0
|
作者
Le, QT [1 ]
Ho, A [1 ]
Cotrutz, C [1 ]
Wakelee, H [1 ]
Kee, ST [1 ]
Donington, I [1 ]
Whyte, RI [1 ]
机构
[1] Stanford Univ, Stanford, CA 94305 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
7231
引用
收藏
页码:673S / 673S
页数:1
相关论文
共 50 条
  • [41] Phase I feasibility and dose escalation multicenter trial of stereotactic body radiation therapy for liver metastases
    Schefter, TE
    Kavanagh, BD
    Timmerman, RD
    Cardenes, HR
    Gaspar, LE
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 352S - 352S
  • [42] Toxicity and Efficacy Results From a Phase I Dose-Escalation Study of Single-Fraction Stereotactic Radiation Therapy for Liver Metastases
    Meyer, J. J.
    Foster, R.
    Lev-Cohain, N.
    Yokoo, T.
    Schwarz, R.
    Rule, W.
    Solberg, T.
    Timmerman, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S51 - S51
  • [43] Once-daily oral afatinib (A) combined with pemetrexed (P) in patients (pts) with advanced solid tumors: A phase I dose escalation trial.
    Chu, Quincy
    Sangha, Randeep
    Hotte, Sebastien J.
    Deng, Qiqi
    Gyorffy, Steve
    Chand, Vikram K.
    Hirte, Hal W.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [44] Outcome after Single-fraction Stereotactic Radiosurgery for Lumbar and Sacral Tumors of the Spine
    Marina, O.
    Angelov, L.
    Djemiil, T.
    Suh, J. H.
    Chao, S. T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S502 - S503
  • [45] SULFASALAZINE AS RADIOSENSITIZER IN COMBINATION WITH STEREOTACTIC RADIOSURGERY FOR RECURRENT GLIOBLASTOMA - A PHASE 1 DOSE-ESCALATION
    Skeie, B.
    Bragstad, S. M.
    Sarowar, S.
    Goplen, D. K. P.
    Heggdal, J., I
    Enger, P.
    NEURO-ONCOLOGY, 2024, 26
  • [46] Phase I dose escalation trial of biweekly pemetrexed in combination with docetaxel in advanced solid tumors
    Garland, L. L.
    Cranmer, L., III
    Gerstner, G.
    Walker, R.
    Obregon, Y.
    Ebbinghaus, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [47] Phase I dose escalation study of fractionated stereotactic radiosurgery (fSRS) for recurrent squamous cell carcinoma of the head and neck (SCCHN)
    Heron, D. E.
    Ferris, R. L.
    Burton, S.
    Lai, S.
    Karamouzis, M. V.
    Gooding, W.
    Johnson, J.
    Smith, R. P.
    Argiris, A.
    Grandis, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [48] Single- and Multi-Fraction Stereotactic Radiosurgery Dose Tolerances of the Optic Pathways
    Milano, Michael T.
    Grimm, Jimm
    Soltys, Scott G.
    Yorke, Ellen
    Moiseenko, Vitali
    Tome, Wolfgang A.
    Sahgal, Arjun
    Xue, Jinyu
    Ma, Lijun
    Solberg, Timothy D.
    Kirkpatrick, John P.
    Constine, Louis S.
    Flickinger, John C.
    Marks, Lawrence B.
    El Naqa, Issam
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 110 (01): : 87 - 99
  • [49] Phase I dose escalation trial of nintedanib in combination with pembrolizumab in patients with advanced solid tumors (PEMBIB trial)
    Baldini, C.
    Danlos, F-X.
    Varga, A.
    Halse, H.
    Mouraud, S.
    Cassard, L.
    Bredel, D.
    Escriou, G.
    Parpaleix, A.
    Rafie, S.
    Abbassi, A. E.
    Laghouati, S.
    Farhane, S.
    Tselikas, L.
    Texier, M.
    Adam, J.
    Chaput, N.
    Soria, J-C.
    Massard, C.
    Marabelle, A.
    ANNALS OF ONCOLOGY, 2021, 32 : S842 - S843
  • [50] Single Fraction Stereotactic Body Radiotherapy for Liver Metastasis: Phase I Dose Finding Results
    Tzou, K. S.
    Vallow, L.
    Atherton, P. J.
    Peterson, J.
    Ko, S.
    Serago, C.
    Kim, G.
    Paz-Fumagalli, R.
    Bridges, M. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S579 - S579